Natco Pharma Ltd - Board Meeting Intimation for Considering The Un-Audited Financial Results For The Quarter Ended 30Th June, 2025 And Declaration Of Interim Dividend For The FY25-26

Download	< Back
04:00 PM
Natco Pharma Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/08/2025 ,inter alia, to consider and approve the Un-audited Financial Results for the quarter ended 30th June, 2025 and declaration of Interim Dividend for the FY25-26
View all announcements for Natco Pharma Ltd	Source: BSE India